# Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

> **NCT02663232** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 264 (actual)

## Conditions studied

- Metastatic Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02663232
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663232, "Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02663232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*